|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-1-10
|
|
pubmed:abstractText |
To determine whether diabetic nephropathy is a risk factor for silent cerebral infarction and whether antiplatelet drug dilazep dihydrochloride decreases the occurrence of silent cerebral infarction in type 2 diabetes patients with microalbuminuria.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1520-7552
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2004 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
39-43
|
|
pubmed:meshHeading |
pubmed-meshheading:15386824-Adult,
pubmed-meshheading:15386824-Aged,
pubmed-meshheading:15386824-Brain,
pubmed-meshheading:15386824-Cerebral Infarction,
pubmed-meshheading:15386824-Diabetic Angiopathies,
pubmed-meshheading:15386824-Diabetic Nephropathies,
pubmed-meshheading:15386824-Dilazep,
pubmed-meshheading:15386824-Female,
pubmed-meshheading:15386824-Humans,
pubmed-meshheading:15386824-Magnetic Resonance Imaging,
pubmed-meshheading:15386824-Male,
pubmed-meshheading:15386824-Middle Aged,
pubmed-meshheading:15386824-Platelet Aggregation Inhibitors,
pubmed-meshheading:15386824-Reference Values,
pubmed-meshheading:15386824-Risk Factors,
pubmed-meshheading:15386824-Vasodilator Agents
|
|
pubmed:articleTitle |
Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
|
|
pubmed:affiliation |
Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
